We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-14.6%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$68.5B
AUM Growth
-$9.16B
(-12%)
Cap. Flow
+$4.06B
Cap. Flow
% of AUM
5.93%
Top 10 Holdings %
Top 10 Hldgs %
21.45%
Holding
3,375
New
359
Increased
2,433
Reduced
285
Closed
282
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$124M |
| 2 |
Apple
AAPL
|
+$110M |
| 3 |
Microsoft
MSFT
|
+$104M |
| 4 |
Amazon
AMZN
|
+$71.3M |
| 5 |
Warner Bros
WBD
|
+$69.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$61.6M |
| 2 |
CERN
Cerner Corp
CERN
|
+$50.9M |
| 3 |
NXP Semiconductors
NXPI
|
+$31.4M |
| 4 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$30.4M |
| 5 |
Yum China
YUMC
|
+$16.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.13% |
| 2 | Healthcare | 14.42% |
| 3 | Financials | 13.45% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Blue Ridge Bankshares
BRBS
$332M
| $383K | ﹤0.01% |
24,993
+7,870
| +46% | +$117K |
|
|
PSTL
2627
Postal Realty Trust
PSTL
$699M
| $383K | ﹤0.01% |
25,712
+9,088
| +55% | +$145K |
|
2628
Fluence Energy
FLNC
$2.44B
| $382K | ﹤0.01% |
40,315
+12,153
| +43% | +$118K |
|
2629
Safe Bulkers
SB
$774M
| $382K | ﹤0.01% |
100,006
+24,301
| +32% | +$104K |
|
|
SBOW
2630
DELISTED
SilverBow Resources, Inc.
SBOW
| $380K | ﹤0.01% |
+13,390
| New | +$489K |
|
|
SRTA
2631
Strata Critical Medical Inc
SRTA
$512M
| $378K | ﹤0.01% |
+84,765
| New | +$612K |
|
2632
Lifecore Biomedical
LFCR
$190M
| $378K | ﹤0.01% |
37,881
+1,471
| +4% | +$14.6K |
|
2633
BioXcel Therapeutics
BTAI
$27.8M
| $376K | ﹤0.01% |
1,782
+644
| +57% | +$135K |
|
2634
ImmunityBio
IBRX
$8.1B
| $376K | ﹤0.01% |
101,032
+12,909
| +15% | +$51.9K |
|
2635
Tarsus Pharmaceuticals
TARS
$2.84B
| $376K | ﹤0.01% |
+25,762
| New | +$387K |
|
|
QUOT
2636
DELISTED
Quotient Technology Inc
QUOT
| $376K | ﹤0.01% |
126,717
+31,498
| +33% | +$149K |
|
|
AKRO
2637
DELISTED
Akero Therapeutics
AKRO
| $374K | ﹤0.01% |
39,586
+13,166
| +50% | +$137K |
|
2638
1-800-Flowers.com
FLWS
$258M
| $373K | ﹤0.01% |
39,179
+9,311
| +31% | +$103K |
|
2639
Centrus Energy
LEU
$3.76B
| $373K | ﹤0.01% |
15,060
+3,122
| +26% | +$86.3K |
|
2640
Radiant Logistics
RLGT
$395M
| $373K | ﹤0.01% |
50,327
-1,548
| -3% | -$9.95K |
|
|
INBX
2641
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $373K | ﹤0.01% |
32,844
+4,435
| +16% | +$65.2K |
|
|
EGIO
2642
DELISTED
Edgio, Inc. Common Stock
EGIO
| $372K | ﹤0.01% |
4,029
-124
| -3% | -$17.8K |
|
2643
Allstate Corp
ALL.PRH
$885M
| $371K | ﹤0.01% |
+16,600
| New | +$381K |
|
2644
Donegal Group Class A
DGICA
$714M
| $371K | ﹤0.01% |
21,775
+5,168
| +31% | +$77.5K |
|
|
NESR
2645
National Energy Services Reunited Corp
NESR
$2.93B
| $371K | ﹤0.01% |
54,691
+11,148
| +26% | +$81.1K |
|
2646
Portillo's
PTLO
$321M
| $367K | ﹤0.01% |
22,468
-2,522
| -10% | -$48.7K |
|
2647
Viridian Therapeutics
VRDN
$2.67B
| $367K | ﹤0.01% |
+31,713
| New | +$426K |
|
2648
Arbutus Biopharma
ABUS
$915M
| $366K | ﹤0.01% |
134,924
+31,146
| +30% | +$79.7K |
|
|
ATH.PRA
2649
Athene Holding Ltd Series A
ATH.PRA
$825M
| $366K | ﹤0.01% |
+14,875
| New | +$374K |
|
2650
BayCom
BCML
$333M
| $366K | ﹤0.01% |
+17,720
| New | +$391K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2022 Portfolio in Review
As of Q2 2022, RhumbLine Advisers held 3,375 positions worth $68.5B, down 12% from $77.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers deployed $4.06B of net new capital in Q2 2022, opening 359 new positions and adding to 2,433 existing holdings. Its largest new stake was Aspen Technology Inc: 81,883 shares worth $15M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was AT&T, an estimated $61.6M trimmed.
- RhumbLine Advisers's largest Q2 2022 buy was Aspen Technology Inc: 81,883 shares worth $15M.
- RhumbLine Advisers added most to Linde in Q2 2022, an estimated $124M increase.
- RhumbLine Advisers's biggest Q2 2022 reduction was AT&T, cutting an estimated $61.6M.
- RhumbLine Advisers fully exited Cerner Corp in Q2 2022, selling an estimated $50.9M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $68.5B portfolio in Q2 2022.
- RhumbLine Advisers opened 359 new positions and closed 282 in Q2 2022.
- RhumbLine Advisers's portfolio value fell 12% quarter-over-quarter to $68.5B.
Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.